Dr. Dawson on the Addition of SBRT to Sorafenib in Locally Advanced HCC
January 21st 2023Laura Dawson, MD, FRCPC, discusses results from the phase 3 NRG/RTOG 1112 trial of stereotactic body radiation therapy plus sorafenib compared with sorafenib alone in patients with locally advanced hepatocellular carcinoma.
Read More